Tag Archives: Type 1 Diabetes

Insights: The Lucrative Business Of Diabetes (2022)

In our modern consumer society, Type 2 diabetes has become a widespread disease. Companies are developing drugs that are increasingly expensive, but not necessarily more effective. Health authorities are powerless. Diabetes is spreading rapidly, all over the world. The disease destroys lives and puts a strain on public budgets.

The UN is calling on governments to take action. Diabetes is proof that modern societies are incapable of adequately treating chronic disease. It affects around 430 million people worldwide, with two main metabolic disorders falling under the name diabetes. Type 1 is an autoimmune disease that must be treated with lifelong doses of insulin, while type 2 can develop when a person’s diet is too high in fat and sugar and they do not engage in enough physical activity.

With turnover of $46 billion, diabetes is a massive and extremely lucrative market. Constantly promised miracle cures have not led to satisfactory treatment, with patients either taking too many drugs or no longer being able to afford them. It’s a desperate situation, and the only ones benefiting seem to be pharmaceutical companies. A medical focus on blood glucose levels has led to an overreliance on medication, sometimes without due concern for dangerous side effects.

Patients become trapped in a cycle of treatment, which in many cases still does not halt the disease’s progression. This can lead to amputations, blindness and heart attacks. And yet there are alternatives that could flatten the curve of the type 2 diabetes epidemic, while reducing health care spending. Improved diet can be a preventative measure, and a strict adherence to diet can also bring about remission in the case of Type 2 diabetes.

But these solutions require effort, as well as a complete rethinking of chronic disease management. Filmed on three continents, this documentary features industry whistleblowers, patients, researchers and medical professionals. It also confronts pharmaceutical companies about their responsibility for the situation.

Diabetes: Understanding Insulin And Islets (Video)

Type 1 and type 2 diabetes are characterized by increased blood glucose levels. They affect almost half a billion people around the globe, and this number is projected to rise as we reach the middle of the century. In most individuals, blood glucose levels are kept within a healthy range by a hormone called insulin, which is secreted by the pancreas, but this fine-tuned regulation can go wrong in type 1 and type 2 diabetes. In this animation, we lay out our current understanding of these diseases and explore active areas of research that aim to restore the body’s blood glucose control.

Read more in https://www.nature.com/articles/d4285…

Science: Metabolic Health Markers & Obesity, Type 1 Diabetes, “Bone Rooms”

First this week, Staff Writer Jennifer Couzin-Frankel joins host Sarah Crespi to discuss the paradox of metabolically healthy obesity. They chat about the latest research into the relationships between markers of metabolic health—such as glucose or cholesterol levels in the blood—and obesity. They aren’t as tied as you might think.

Next, Colin Dayan, professor of clinical diabetes and metabolism at Cardiff University and senior clinical researcher at the Wellcome Centre for Human Genetics at the University of Oxford, joins Sarah to discuss his contribution to a special issue on type 1 diabetes. In his review, Colin and colleagues lay out research into how type 1 diabetes can be detected early, delayed, and maybe even one day prevented. Finally, in the first of a six-patrt series of book interviews on race and science, guest host Angela Saini talks with author and professor of history at the University of Massachusetts, Amherst, Samuel Redman, about his book Bone Rooms: From Scientific Racism to Human Prehistory in Museums. The two discuss the legacy of human bone collecting and racism in museums today. 

Top Journals: Science Magazine – July 30, 2021

Medical History: The Discovery Of Insulin

Nearly 100 years since insulin was first used in the treatment of diabetes, Professor Chantal Mathieu, Professor of Medicine at the Katholieke Universiteit Leuven, Belgium, takes us through the history, development and future of this life saving drug. Read more in https://www.nature.com/articles/d4285…

Healthcare Podcast: Price Of Insulin Has Doubled In Last 4 Years, Putting Type 1 Diabetics & Families At Risk

From a USA Today online article:

USA-Today-webIn people with Type 1 diabetes, the pancreas can’t make insulin. Those with the condition require several doses of insulin a day and spent $5,705 per person on it in 2016, an increase of $2,841, or 99%, per person since 2012, according to the nonprofit Health Care Cost Institute.

(Podcast interview “This Weekend With Gordon Deal”, 12-14-19)

This Weekend with Gordon Deal podcastCosts continue to rise, so much so that almost half of people with diabetes have temporarily skipped taking their insulin, according to a 2018 survey by UpWell Health, a Salt Lake City company that provides home delivery of medications and supplies for chronic conditions.

“Insulin prices doubled in a four-year period,” said Cathy Paessun, the director of the Central Ohio Diabetes Association. “They continue to go up, and the infuriating thing is that there is no change in the process for creating the product.”

To read article: https://www.usatoday.com/story/news/health/2019/12/09/insulin-prices-double-ohio-lawmakers-looking-answers/2629115001/